VITR.ST - Vitrolife AB (publ)
NEXT EARNINGS:
Apr 23, 2026
EPS Est: $0.82
|
Rev Est: $826.2M
Price:
--
--
Market Cap:
12.09B
Volume:
178,686
Avg Volume:
304,676
52 Week Range:
84.9-206.4
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
2.06
Last Dividend:
$1.10
Exchange:
STO
Country:
SE
Employees:
1,150
IPO Date:
2001-06-28
EPS (TTM):
-37.01
P/E Ratio:
-3.70
Revenue (TTM):
3.44B
Total Assets:
11.12B
Total Debt:
1.68B
Cash & Equiv:
809.00M
Rev Growth (5Y):
22.5%
EPS Growth (5Y):
1.4%
FCF Growth (5Y):
1.6%
ROCE:
-46.0%
Debt/Equity:
0.21
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-03 | $-39.24 | $-12.34 | -218.0% | $891.0M | $826.2M | +7.8% |
| 2025-04-24 | $0.74 | $0.91 | -18.7% | $842.0M | $925.0M | -9.0% |
| 2025-01-30 | $1.02 | $1.20 | -15.0% | $959.0M | $909.0M | +5.5% |
| 2024-10-24 | $0.85 | $1.07 | -20.6% | $867.0M | $918.4M | -5.6% |
| 2024-07-17 | $1.06 | $1.01 | +5.0% | $941.0M | $915.2M | +2.8% |
| 2024-04-18 | $0.85 | $0.92 | -7.6% | $841.0M | $871.3M | -3.5% |
| 2024-02-02 | $0.89 | $1.02 | -12.7% | $904.0M | $897.3M | +0.7% |
| 2023-10-27 | $0.90 | $0.79 | +13.9% | $848.0M | $872.2M | -2.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.44B | 3.61B | 3.51B | 3.23B | 1.68B | 1.25B | 1.48B | 1.15B | 1.05B | 856.11M | 722.37M | 510.51M |
| Net Income | (5.01B) | 513.00M | (3.85B) | 394.00M | 341.00M | 286.85M | 382.79M | 309.70M | 263.64M | 190.37M | 182.84M | 109.11M |
| EPS | -37.01 | 3.79 | -28.44 | 2.91 | 2.97 | 2.64 | 3.53 | 2.85 | 2.43 | 1.75 | 1.68 | 1.09 |
| Total Assets | 11.12B | 17.45B | 16.33B | 20.55B | 19.43B | 2.31B | 2.14B | 1.70B | 1.42B | 1.25B | 1.06B | 972.48M |
| Total Debt | 1.68B | 2.09B | 2.09B | 2.23B | 2.48B | 62.40M | 75.84M | 0 | 480,000 | 37.86M | 47.50M | 85.79M |
| Cash & Equivalents | 809.00M | 1.14B | 861.00M | 578.00M | 630.09M | 973.57M | 689.54M | 490.81M | 395.96M | 189.25M | 199.57M | 107.60M |
| Operating Cash Flow | 635.00M | 907.00M | 757.00M | 636.00M | 384.31M | 356.45M | 413.33M | 349.44M | 312.19M | 181.26M | 193.53M | 145.67M |
| Free Cash Flow | 365.00M | 907.00M | 638.00M | 549.00M | 321.86M | 336.36M | 326.23M | 169.33M | 301.72M | 167.51M | 170.90M | 136.75M |
| FCF per Share | 2.70 | 6.70 | 4.71 | 4.05 | 2.81 | 3.10 | 3.01 | 1.56 | 2.78 | 1.54 | 1.57 | 1.37 |
| Book Value | 7.89B | 13.64B | 12.72B | 16.74B | 15.32B | 2.01B | 1.79B | 1.49B | 1.23B | 1.02B | 843.15M | 700.91M |
| Cash & ST Investments | 809.00M | 1.14B | 861.00M | 578.00M | 630.09M | 973.57M | 689.54M | 490.81M | 395.96M | 189.25M | 199.57M | 107.60M |
| ROC Equity | -0.64 | 0.04 | -0.30 | 0.02 | 0.02 | 0.14 | 0.21 | 0.21 | 0.22 | 0.19 | 0.22 | 0.16 |